Divis Laboratories Ltd | DIVI - Sales Revenues

Stock Price
5,968.50
Daily Change
-33.50 -0.56%
Monthly
-6.21%
Yearly
1.43%
Q1 Forecast
5,937.24

Divis Laboratories Ltd reported INR27.15B in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Alaunos Therapeutics USD 2K 2K Mar/2025
Aurobindo Pharma INR 82.86B 4.18B Sep/2025
Avita Medical AUD 18.42M 14K Jun/2025
Dianthus Therapeutics USD 396K 203K Sep/2025
Divis Laboratories Ltd INR 27.15B 3.05B Sep/2025
Ionis Pharmaceuticals USD 157M 295M Sep/2025
IQVIA Holdings USD 4.1B 80M Sep/2025
Lupin INR 70.48B 7.75B Sep/2025
Moderna USD 1.02B 878M Sep/2025
Organon & Co USD 1.6B 10M Sep/2025
Revvity USD 772.06M 73.06M Dec/2025
Tectonic Therapeutic USD 0 0 Dec/2024
Tilray USD 217.51M 74.75M Dec/2025
Viatris USD 3.76B 190M Sep/2025
Xeris Pharmaceuticals USD 74.38M 2.84M Sep/2025